Compounds > adenine

adenine and epoxyfarnesyl diazoacetate

adenine has been researched along with epoxyfarnesyl diazoacetate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Didier, PJ; Michael, H; Mitsuya, H; Murphey-Corb, M; Nyaundi, J; Parniak, MA; Rajakumar, P; Reeve, AB; Sarafianos, SG1
Hachiya, A; Huber, AD; Jackson, JC; Kirby, KA; Kodama, EN; Leslie, MD; Marchand, B; Michailidis, E; Mitsuya, H; Ong, YT; Parniak, MA; Ryan, EM; Sarafianos, SG; Singh, K1
Aoki, M; Desai, DV; Kodama, EN; Maeda, K; Mitsuya, H; Nakata, H1
Jones, J; Taylor, BS; Tieu, HV; Wilkin, TJ1
Aralaguppe, SG; Neogi, U; Njenda, DT; Rao, R; Sarafianos, SG; Singh, K; Sönnerborg, A1
Coelho, LE; Grinsztejn, B; Landovitz, RJ; Torres, TS; Veloso, VG1

Reviews

1 review(s) available for adenine and epoxyfarnesyl diazoacetate

ArticleYear
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline.
    The lancet. HIV, 2019, Volume: 6, Issue:11

    Topics: Adenine; Administration, Cutaneous; Administration, Oral; Alanine; Contraceptive Devices, Female; Delayed-Action Preparations; Deoxyadenosines; Emtricitabine; Female; HIV Infections; Humans; Incidence; Male; Medication Adherence; Pre-Exposure Prophylaxis; Tenofovir

2019

Other Studies

5 other study(ies) available for adenine and epoxyfarnesyl diazoacetate

ArticleYear
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adenine; Animals; Antiviral Agents; Cells, Cultured; Deoxyadenosines; Deoxycytidine; Emtricitabine; Leukocytes, Mononuclear; Macaca mulatta; Male; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Load; Zidovudine

2012
Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA.
    Retrovirology, 2013, Jun-24, Volume: 10

    Topics: Adenine; Anti-HIV Agents; Cell Line; Deoxyadenosines; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutant Proteins; Mutation, Missense; Organophosphonates; Tenofovir

2013
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001.
    Antiviral therapy, 2014, Volume: 19, Issue:2

    Topics: Adenine; Amino Acid Sequence; Anti-HIV Agents; Deoxyadenosines; Deoxycytidine; Drug Resistance, Multiple, Viral; Emtricitabine; HIV Infections; HIV-1; Human Immunodeficiency Virus Proteins; Humans; Lamivudine; Molecular Sequence Data; Molecular Structure; Organophosphonates; Tenofovir; Thymidine

2014
CROI 2018: Advances in Antiretroviral Therapy.
    Topics in antiviral medicine, 2018, Volume: 26, Issue:1

    Topics: Adenine; Amides; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Congresses as Topic; Deoxyadenosines; Drug Therapy, Combination; Emtricitabine; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV-1; Humans; Piperazines; Pyridones; Tenofovir; Viral Load

2018
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes.
    The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10

    Topics: Adenine; Alanine; Anti-Retroviral Agents; Deoxyadenosines; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Recombination, Genetic; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure

2018